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Abstract
Background: New bioimaging techniques capable of visualising the co-location of numerous proteins within
individual cells have been proposed to study tumour heterogeneity of neighbouring cells within the same tissue
specimen. These techniques have highlighted the need to better understand the interplay between proteins in terms
of their colocalisation.
Results: We recently proposed a cellular-level model of the healthy and cancerous colonic crypt microenvironments.
Here, we extend the model to include detailed models of protein expression to generate synthetic multiplex
fluorescence data. As a first step, we present models for various cell organelles learned from real immunofluorescence
data from the Human Protein Atlas. Comparison between the distribution of various features obtained from the real
and synthetic organelles has shown very good agreement. This has included both features that have been used as
part of the model input and ones that have not been explicitly considered. We then develop models for six proteins
which are important colorectal cancer biomarkers and are associated with microsatellite instability, namely MLH1,
PMS2, MSH2, MSH6, P53 and PTEN. The protein models include their complex expression patterns and which cell
phenotypes express them. The models have been validated by comparing distributions of real and synthesised
parameters and by application of frameworks for analysing multiplex immunofluorescence image data.
Conclusions: The six proteins have been chosen as a case study to illustrate how the model can be used to generate
synthetic multiplex immunofluorescence data. Further proteins could be included within the model in a similar
manner to enable the study of a larger set of proteins of interest and their interactions. To the best of our knowledge,
this is the first model for expression of multiple proteins in anatomically intact tissue, rather than within cells in culture.
Keywords: Multiplex fluorescence imaging, Colorectal tissue architecture, Subcellular protein expression, Protein
expression modelling
Background
Recent popularity of multiplex immunofluorescence (IF)
imaging is generating massive amounts of digital image
data. In consequence, the demand for development of
robust analytical methods for quantitative analysis of the
image data is on the rise. Realistic synthetic data could
provide an objective way of validating and comparing
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such methods. Building accurate protein expression mod-
els requires taking into account their spatial distributions
since the subcellular location of a protein is so critical to
its function that the same protein can have different func-
tions at different locations [1]. The Virtual Cell project [2]
enables the formulation of both compartmental and spa-
tial partial differential equation models. Similarly, Monte
Carlo Cell (MCell) and Smoldyn [3, 4] use agent-based
methods which simulate each molecule individually and
evaluate their diffusion and probability of interactions on
a per-particle basis for each time step. Although compu-
tationally extremely expensive, these methods have high
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spatial resolution and are successful at modelling inter-
actions of small numbers of heterogeneously distributed
molecules.
While the above methods can be useful for studying the
dynamics of protein interaction, they do little to model
the microscopic level cell structure, which is necessary
for validation of image analysis methods such as cell-
compartment classification methods [5–9]. To address
this issue, Zhao and Murphy [10] presented a machine
learning method to generate realistic cells with labelled
nuclei, membranes and a protein expressed in a cell
organelle. Parameters for these models were learned from
real images of cells in culture. However, these genera-
tive models are restricted to individual cells in culture
and only one protein of interest at a time. Hence, they
do not capture the dynamic interplay between important
proteins localised in certain cell compartments in anatom-
ically intact tissue as opposed to freely moving cells in
culture.
Other frameworks for generating synthetic IF data
include the SIMCEP simulator, which can simulate large
2D cell populations with realistically looking cytoplasm,
nuclei and cell organelle [11]. Svoboda et al. [12] gener-
ated a model to fully simulate 3D image data of cell nuclei,
with realistic distribution [13], and later of healthy colon
tissue [14]. However, thesemodels only include cell nuclei.
In addition, the shape of the nuclei in the colon tissue
model of [14] is not very realistic due to the presence of
sharp corners generated from Voronoi diagrams and does
not reflect the variety of cell phenotypes found in real
tissue. Heterogeneous cell populations expressing differ-
ent protein markers can be simulated using the SimuCell
toolbox [15]. The first method for simulating bright-field
microscopy was proposed for synthesising cervical smears
[16]. However, tissue microenvironment was not taken
into account in that work. More recently, a model has
been proposed for simulating the microenvironment of
healthy and cancerous colon tissue [17, 18]. This model
has a number of user-defined parameters that allow con-
trol over the tissue appearance and is capable of simulating
microscopy images for cancers of various differentiation
grade.
Healthy colon tissue microenvironment is composed
of a single layer of epithelium forming glandular struc-
tures, called crypts (as shown in Fig. 1). The crypts consist
mostly of three types of cells: epithelial (absorptive) cells,
goblet cells, and stem cells (Fig. 1), and extend down to sit
on themuscularis mucosae. Stroma fills the space between
the crypts and contains several types of cells, such as lym-
phocytes, plasma cells and fibroblasts. As the colorectal
adenocarcinoma (CRA) develops from normal tissue, the
epithelium exhibits increased dysplasia (pre-malignant
change with disordered growth and mutation) and there
are fewer mucus-containing goblet cells, reflecting a lack
Fig. 1 A Hematoxilyn and Eosin (H&E) image depicting the structure
of healthy colon tissue
of normal cellular differentiation. CRA is a heterogeneous
group of diseases which have distinctive genetic and epi-
genetic basis [19]. It arises following one of the three
pathways: microsatellite instability (MSI), chromosomal
instability (CIN) or CpG island methylator phenotype
(CIMP) pathways. The CIN pathway is the most common
and is characterised by widespread imbalances in chro-
mosome number and loss of heterozygosity (loss of an
entire gene). It can result from accumulation of muta-
tions in specific tumour suppressor genes and oncogenes
that activate pathways critical for CRA such as chromoso-
mal segregation, telomere stability, and the DNA damage
response [20]. On the other hand, epigenetic instability
is now believed to be implicated in the pathogenesis of
almost one third of colorectal cancers [21]. CRAs with
CIMP are characterised by epigenetic loss of function of
tumour suppressor genes without mutations [21, 22]. The
MSI pathway is discussed in more detail below.
Microsatellites are simple repeat sequences of 1 to 6
base pairs (also known as short tandem repeats) and are
particularly prone to replication errors. Defects in one
of the four DNA mismatch repair (MMR) genes (MLH1,
MSH2, MSH6, PMS2) cause small changes in the num-
ber of repeats of microsatellites throughout the genome,
consequently resulting in the development of the MSI.
Mismatch repair is a complex process that depends on
the MMR proteins and multiple proteins that interact
directly with the DNA [23]. The MSH2 and MSH6 pro-
teins exist as a heterodimer, which forms a sliding clamp
on the DNA strand. When MSH2 recognises a DNA base
pair mismatch, it recruits the MLH1-PMS2 heterodimer.
Repairing the mismatch requires coordinated activity of
DNA repair proteins and the precise mechanisms are still
under investigation [24, 25].
Around 15 % of CRAs are characterised by a high
degree of MSI (MSI-high) [24], and of these, about 1 in
5 (3–5 % overall, [26]) are due to Lynch syndrome (LS),
previously known as hereditary nonpolyposis colorectal
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cancer (HNPCC). LS is the most common inherited CRA
syndrome and it predisposes the patient to cancers of mul-
tiple organ systems, including the gastrointestinal tract.
It is important to identify patients with LS as it allows
for increased surveillance of the affected individual and of
potentially affected family members. Hence, preliminary
screening is often done using IHC to detect MSI. Most
MSI-high CRAs are caused by epigenetic silencing of the
MLH1 gene (≈ 50 %) or the MSH2 gene (≈ 40 %) [27].
Mutations inMSH6 and PMS2 occur only in about 10 % of
LS patients [28, 29]. In addition, Samowitz et al. [30] con-
sidered the relationship between P53 mutations and MSI
in CRAs. The study considered mutation in the P53 gene
to be indicated by over-expression (over 50 % of tumour
cells expressing) of the protein in immunohistochemistry
(IHC) data. They found that P53 over-expression occurred
in 56 % of microsatellite stable tumours and only 20 % of
unstable tumours.
In this work, we propose models for subcellular expres-
sion of proteins associated with MSI, namely MLH1,
MSH2, MSH6 and PMS2, and tumour suppressor pro-
teins, such as P53 and PTEN. These proteins were selected
as a case study to illustrate how a variety of proteins can be
included within the framework to enable the generation
of synthetic multiplex fluorescence image data of both
healthy and cancerous tissue samples. The models have
been integrated within a model of the tumour microen-
vironment of colorectal cancer [17, 18], and take into
account the cell phenotypes present in the tissue as well
as the presence of relevant gene mutations. We have also
developed models for a number of subcellular organelles,
which were learned from real high-resolution confocal
microscopy images. We have validated the models by
comparing the distributions of morphological features of
the cell organelles, by performing combinatorial molecu-
lar phenotype analysis, and by constructing the cell-level
protein co-localisation networks. The analysis has demon-
strated that themodel generates realistic image data which
could be used to validate and compare various image
analysis methods such as cell-compartment classification
methods, frameworks for studying protein co-localisation
or protein expression grading.
To the best of our knowledge, this is the first model
for expression of multiple proteins in anatomically intact
tissue, rather than within cells in culture.
Methods
It is important to study tumour heterogeneity and the
MSI, as they could guide treatment and help diagnose
Lynch syndrome. We have considered the four MMR pro-
teins (MLH1, PMS2, MSH2, MSH6). Mutations in genes
producing these proteins are the cause for MSI. In addi-
tion, we consider P53 which has been found to be also
associated with the condition [30] and PTEN which is
Table 1 Details of the subcellular location of proteins obtained
from the Human Protein Atlas (HPA) [31]
Protein Subcellular location
MLH1 Nucleoli, weak expression in the nucleus and cytoplasm
PMS2 Nucleus but not nucleoli, weak expression in cytoplasm
MSH2 Nucleus but not nucleoli, vesicles
MSH6 Mainly in the nucleus but not nucleoli. In addition localised to
the cytoplasm, golgi apparatus & vesicles.
P53 Nucleus but not nucleoli
PTEN Nucleus but not nucleoli and in the cytoplasm
an important CRA biomarker. These proteins have var-
ied subcellular expression patterns (Table 1) and provide
an interesting case study demonstrating how several dif-
ferent protein expressions could be included within the
proposed model.
In order to model the expression of proteins, we first
need to have models for the cell organelles where the
proteins of interest are expressed. These are detailed in
Table 1. We use real confocal IF data from the Human
Protein Atlas (HPA, http://proteinatlas.org) [31] to learn
features of the organelles that can then be incorporated
into the model. The IF images of cultured cells are utilised
instead of the IHC images of CRA since the latter do not
provide high enough resolution to consider the subcel-
lular protein expression patterns. Once we have realistic
models for the cell organelles, we then develop models for
the proteins based on where they are expressed and under
what conditions. Details of this process are given below.
Learning from the real data
We have utilised high resolution IF images of cultured
cells from the HPA [31] for learning parameters for our
model. In order to model the proteins of interest, we need
to developmodels for the nucleoli, golgi apparatus and the
vesicles. For each organelle, we have used proteins known
to be highly specific to that organelle. To obtain sufficient
data, we have used 2 or 3 proteins for each cell organelle,
as detailed in Table 2. For each cell organelle, we consider
a total of 10 images split nearly evenly between the pro-
teins, with the number of images used for each protein
depending on howmany good quality images are available.
In order to learn from the real IF data, we first need
to segment the individual cells, nuclei and cell organelles.
Table 2 Proteins tags used for modelling cell organelles
Cell organelle Protein tags
Nucleoli MLH1 & RRP1B
Golgi GOLGA2 & GORASP2
Vesicles ABCD3, PSAP & PECR
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Fig. 2 Examples of cell and nuclear segmentation. a and c show the original ER and nuclear channels. b and d show the segmentation borders in red
Fig. 3 Examples of nucleoli segmentation. a and c show the original channels for MLH1 and RRP1B images, respectively. b shows segmentation
results from the seeded watershed segmentation method with borders shown in red. d shows segmentation results from the adaptive thresholding
method
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Fig. 4 Examples of golgi segmentation. a shows the original channel for a GOLGA2 image. b shows segmentation results from the adaptive
thresholding method with borders shown in red. c shows segmentation results from the seeded watershed segmentation method
Fig. 5 Examples of vesicles segmentation. a shows the original channel for an ABCD3 image. b and e show enlarged sections of the original
channels for ABCD3 and PSAP images, respectively. c and f show segmentation results from the adaptive thresholding method with borders shown
in red. d shows segmentation results from the seeded watershed segmentation method
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Fig. 6 Estimated probability distribution functions for the number (left column) and position (right column) of the a, b nucleoli, c, d golgi and e, f
vesicles
Cell and nuclear segmentation was performed using the
seeded watershed segmentation method proposed in [32].
The procedure involves thresholding the DAPI image
with the threshold being determined as the intensity
of the most common pixel. Next, the binary nuclear
image is eroded and small objects and objects touch-
ing the boundary of the image are removed. This way
we could ensure that the seeds generated were not as a
result of noise in the image. Nuclei with diameter out-
side the range of [5, 20] μm are considered erroneous
seeds and are also removed. For cell segmentation, the
endoplasmic reticulum (ER) channel was used to deter-
mine background seeds from large areas of pixels with
zero intensity. The seed locations and the inverted ER
image are then used in a seeded watershed algorithm,
which is a segmentation algorithm identifying “catch-
ment basins” and “watershed ridge lines” in an image by
treating it as a surface where light pixels are high and
dark pixels are low. For nuclear segmentation, the nuclear
(DAPI) channel was used to determine both foreground
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Fig. 7 Estimated probability distribution functions for the ratios between the minor axes of the organelles and the nucleus of the corresponding cell
(left column) and between the minor and major axes of the organelles. Figures show the ratios for a, b nucleoli, c, d golgi and e, f vesicles
and background seeds. Examples of the results are shown
in Fig. 2.
For the purpose of segmenting the cell nucleoli, a single
channel showing a relevant antibody was thresholded to
remove background noise and used to obtain both back-
ground and foreground seeds. The same segmentation as
above was then followed. Similarly to above, nucleoli with
diameter outside the range of [0.5, 3] μm are removed.
The results are shown in Fig. 3.
When segmenting the vesicles and golgi apparatus, the
above method didn’t perform satisfactorily due to the
small size of the objects and the high level of noise in the
images (Figs. 4c and 5d). For this reason, we have instead
used an adaptive mean filter to highlight image features
and then Otsu threshold to segment the image (Figs. 4
and 5). Objects containing less than 5 pixels were consid-
ered noise and were discarded. Thresholding is unable to
separate touching organelles. However, this issue would
persist even with more sophisticated algorithms as it is
due to the fact that the pixel resolution is not high enough
to enable one to see whether a large object is a single
large organelle or if it consists of two closely located vesi-
cles. We can see that the method performs very well even
at high levels of noise (Fig. 5f). On the other hand, this
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method tends to over-segment the nucleoli and produces
many false positives (Fig. 3d). The segmentation proce-
dure resulted in 484 nucleoli from 86 cells, 3433 golgi
objects from 83 cells and 12,764 vesicles from 72 cells
being identified.
Once we have all the objects segmented, we can extract
morphological features representing the cell organelles
to be incorporated into the model. We extract several
features describing the organelles and their distribution
within the cell. For each of them, we use maximum like-
lihood estimation to estimate a probability distribution
function (PDF) which is incorporated into the model.
Firstly, we obtain the numbers of organelles within each
segmented cell. These are modelled using a Gamma PDF,
as this distribution provided the best fit, and the results
are shown in Fig. 6 (left column). We then consider the
size and shape of the organelles. Since the real data avail-
able is for different types of cultured cells, instead of
estimating the size of the cell organelles directly, we con-
sider the ratio between the minor axes of the cell organelle
and that of the corresponding nucleus. We assume that
the shape of the cell nucleus is approximately the same in
tissue and in cell culture. The distributions of this ratio
and the estimated Gamma PDFs for each cell organelle
are shown in Fig. 7 (left column). This ratio generalises
better to cells in a tissue and at different magnifications.
To estimate the shape of the organelles, we consider the
ratio between the minor and major axes of the segmented
objects. The distributions of this feature and the estimated
Gamma PDFs for each cell organelle are shown in Fig. 7
(right column).
The last feature considered is the relative position of the
organelle within the cell. We considered the line from the
centre of the cell nucleus going through the centre of the
organelle of interest. Let the distance between the cen-
tre of the nucleus and the point where the line crosses
the nuclear membrane be given by N. Let the distance
between the centres of the nucleus and the organelle be
given byO, and the distance between the points where the
line crosses the nuclear and plasma membranes be given
by C (as shown in Fig. 8). Then, the distance feature is
given by
D = 1 − N − ON + C . (1)
Consequently, the minimum value of D = 1−N/(N +C)
means the organelle is located at the centre of the nucleus
and as D → 1 the cell compartment is located closer to
the nuclear membrane but within the nuclear boundary.
A value of D > 1 describes an organelle that is outside
the nuclear boundary and the distance from it is given
proportionate to the distance between the centre of the
nucleus and the cell membrane. The distributions of this
Fig. 8 Diagram for calculating the position feature. The star marks the
position of the organelle of interest
feature and the estimated PDFs for each cell organelle are
shown in Fig. 6 (right column). The distribution of the
nucleoli position was well estimated by a Gamma PDF.
On the other hand, most of the vesicles and golgi objects
were found close to the nuclear membrane and so a t
Location-Scale distribution gave a better fit.
Modelling cell organelles
For modelling the different cell compartments, we use
the deformed circle model used in Kovacheva et al. [18].
When we are generating cell organelles of a particular
type, we draw model parameter values from the relevant
PDFs as described above. However, we also impose cer-
tain restrictions on the parameter values based on the size
of the cell in consideration. For each cell, first we choose
the number of organelles to be created. We only place a
new cell organelle if that type of organelles are not taking
up more than 12 or 18 % of the cell area for golgi and vesi-
cles, respectively, and 20 % of the nuclear area for nucleoli.
These constraints were set up to address the fact that
other parameter values are drawn independently and so
may result in unrealistic examples where a large number
of organelles with relatively great size are generated. The
values were set based on observations from the real data
where golgi and vesicles took up to 4 and 6 % of the cell
area, and the nucleoli took up to 19.3 % of the nucleus. The
first two values were scaled up as the cytoplasm of cells
in a tissue has more compact shape and so the 2D projec-
tion of it would give a much smaller area. On the other
hand, we don’t expect the nucleus to significantly change
shape and so the threshold was held nearly the same. For
each cell organelle to be placed, we choose the length of
the minor axis by drawing a value for the ratio between
the nuclear minor axis and that of the organelle. A mini-
mum length of 1 pixel is set. To determine the length of
the major axis, we draw a value from the PDF estimated
for the ratio between the minor and major organelle axes.
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Finally, we need to estimate the position of the organelle.
For this, we draw a value from the PDF of the distance
feature and select the direction from the nuclear centre at
random. Using (1), we can then estimate the distance from
the nuclear centre. The resulting organelles are shown in
Fig. 9.
Modelling protein expression
With a view to include an IF channel per protein marker
into the model, three user-defined parameters were intro-
duced per protein. These define whether or not the pro-
tein has been imaged, whether there is a mutation in the
gene, and what fraction of the epithelial cells express the
protein. Six proteins were included in the model, namely
MLH1, PMS2, MSH2, MSH6, P53 and PTEN. The protein
expression within each organelle is generated using a
well-known procedural model [33] for texture synthesis.
Details of each are given below. In addition, the user
could choose to produce samples that are representative
of the population. In that case, the model would include
an MMR protein mutation with a 15 % probability. If a
mutation occurs, it has a probability of 50 % of being in
the MLH1 gene, 40 % in MSH2, 7 % in MSH6, and 3 % in
PMS2 [27]. In cases without mutation, P53 has 50 % prob-
ability of being overexpressed in epithelial cells, whereas
in MSI cases it is overexpressed in only 20 % of the cases
[30].
The subcellular expression for MLH1 was modelled as
described in Table 1 and shown from confocal fluores-
cence images of cultured cells in Fig. 10a, namely the
Fig. 9 Examples of generated cell organelles. In all images the cytoplasm is shown in red, nuclei in blue and the green channel shows a, b the
nucleoli, c, d the golgi and e, f the vesicles. b, d, f show close-up sections of a, c, e, respectively, with the section identified by the green square
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Fig. 10Modelling MLH1. a subcellular location of MLH1 in cultured cells imaged using a confocal fluorescence microscope, bMLH1 expression in a
histology image of CRA; Images a, b are from the HPA. c, d synthetic images for MLH1 with d a scaled up sections from (c). Images are from the
same sample as shown in Fig. 9. In this simulation all cells are expressing the protein
Fig. 11Modelling PMS2. a subcellular location of PMS2 in cultured cells imaged using a confocal fluorescence microscope, b PMS2 expression in a
histology image of CRA; Images a, b are from the HPA. c, d synthetic images for PMS2 with d a scaled up sections from (c). Images are from the
same sample as shown in Fig. 9
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Table 3 Effects of mutations in the MMR genes on protein
expression in epithelial cells
Defective gene Imaging results
MLH1 Loss of MLH1, PMS2
PMS2 Isolated Loss of PMS2
MSH2 Loss of MSH2, MSH6
MSH6 Isolated Loss of MSH6
protein has a strong expression in the nucleoli and weak
expression in the rest of the nucleus. We can see that this
also agrees with what is observed when the cells are in
a tissue (Fig. 10b). If the user specifies a mutation in the
MLH1 gene, the protein is not expressed in the epithe-
lial cells. Otherwise, the user can specify what fraction of
the epithelial cells are expressing the protein. It is worth
noting that, in practice, even if only a small fraction of
epithelial cells express the MMR proteins, the sample is
graded as positively stained. Most stromal cells would
always express the MMR proteins and, in the clinic, this
serves the pathologists as a positive control that the tissue
has been stained.Within themodel, all stromal cells would
always express MLH1. Examples of IF protein marker
images generated are shown in Fig. 10c, d.
The real confocal fluorescence images from HPA
showed strong expression of PMS2 in the nucleus
excluding the nucleoli and weak expression in the cyto-
plasm (Fig. 11a). We can see that this also agrees with
hat is observed when the cells are in a tissue (Fig. 11b). If
the user specifies a mutation in the PMS2 gene, the pro-
tein is not expressed in the epithelial cells. In addition, the
same limited expression would occur if there is a muta-
tion in the MLH1 gene as the two are binding partners
(Table 3). Otherwise, the user can specify what fraction
of the epithelial cells are expressing the protein and these
are taken to be a subset of the epithelial cells expressing
MLH1. As above, all stromal cell would always express
PMS2. Example of synthesised MLH1 protein images are
shown in Fig. 11c, d.
The subcellular expression for MSH2 was modelled as
described in Table 1 and seen in confocal IF images of cul-
tured cells from HPA as shown in Fig. 12a, namely the
protein has a strong expression in the nucleus and weak
expression in the nucleoli. The same expression pattern is
observed when the cells are in tissue (Fig. 12b). To gener-
ate a realistic texture for this protein we use the chromatin
texture used for the nuclear channel of the THeCoTmodel
[18]. If the user specifies a mutation in the MSH2 gene,
the protein is not expressed in the epithelial cells. Oth-
erwise, the user can specify the fraction of the epithelial
Fig. 12Modelling MSH2. a subcellular location of MSH2 in cultured cells imaged using a confocal fluorescence microscope, bMSH2 expression in a
histology image of CRA; a, b are from the HPA. c, d synthetic images for MSH2 with (d) a scaled up sections from (c). Images are from the same
sample as shown in Fig. 9
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Fig. 13Modelling MSH6. a subcellular location of MSH6 in cultured cells imaged using a confocal fluorescence microscope, bMSH6 expression in a
histology image of CRA; Images a, b are from the HPA. c, d synthetic images for MSH6 with (d) a scaled up sections from (c). Images are from the
same sample as shown in Fig. 9
Fig. 14Modelling P53. a subcellular location of P53 in cultured cells imaged using a confocal fluorescence microscope, b P53 expression in a
histology image of CRA; a, b are from the HPA. c, d synthetic images for P53 with (d) a scaled up sections from (c). Images are from the same sample
as shown in Fig. 9
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Fig. 15Modelling PTEN. a subcellular location of PTEN in cultured cells imaged using a confocal fluorescence microscope, b PTEN expression in a
histology image of CRA; a, b are from the HPA. c, d synthetic images for PTEN with (d) a scaled up sections from (c). Images are from the same
sample as shown in Fig. 9
cells expressing the protein. All stromal cells would always
express the molecule. Example of synthetic MSH2 protein
images are shown in Fig. 12c, d.
Both in vivo and in vitro cells have strong expression of
MSH6 in the nucleus excluding the nucleoli, the vesicles
and golgi apparatus, and weak expression in the cytoplasm
(Table 1, Fig. 13a, b). If the user specifies a mutation in
the MSH2 or MSH6 genes, the protein is not expressed
in the epithelial cells (Table 3). Otherwise, the user can
specify what fraction of the epithelial cells are express-
ing the protein and these are taken to be a subset of the
epithelial cells expressing MSH2. As above, all stromal
cells would always express MSH6. Example of synthetic
MSH6 protein images are shown in Fig. 13c, d.
P53 has a strong expression in the nucleus excluding the
nucleoli (Table 1, Fig. 14a, b). Unlike the MMR genes, P53
is not expressed in the stromal cells. Hence, to avoid a
Table 4 Kullback-Leibler divergence between real and synthetic
distributions of features
Number Position Organelle/ Organelle Solidity Area
nucleus ratio axes ratio fraction
Nucleoli 0.06 0.05 0.01 0.07 0.25 0.24
Golgi 0.26 0.24 0.76 0.36 0.68 0.33
Vesicles 0.35 0.41 0.48 0.17 0.08 0.17
blank image in the stack, the model assumes that there is
some expression of the protein in the epithelial cells. The
user can specify what fractions of the epithelial cells are
expressing the protein. Example of synthetic P53 protein
images are shown in Fig. 14c, d.
Similarly, PTEN expression is modelled within the
nucleus but not the nucleoli or in the cytoplasm as shown
in Fig. 14d. Unlike P53, PTEN is expressed in some stro-
mal cells. The fraction of stromal cells expressing it is
chosen at random to be between 30 and 70 %, based on
observations from the real data, an example of which is
shown in Fig. 15b. A sample image showing expression
pattern of this protein marker is shown in Fig. 15.
Results and discussion
We have focussed on six proteins associated with MSI
in colorectal cancer. These are commonly screened for
in clinical practice and developing the protein expres-
sion models could aid the development of frameworks
for automatic grading. The user could choose to have a
sample that is generated with the probability of muta-
tion representative of the general population. In this
case, they also need to specify which of the six pro-
teins they wish to be included in the resulting images.
Alternatively, they can specify where the mutation occurs.
The model takes into account dependencies of binding
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Fig. 16 Probability distributions for the synthesised number (left column) and position (right column) of the a, b nucleoli, c, d golgi and e, f vesicles.
The probability distribution functions shown are the ones estimated for the real data, shown in Fig. 6
pairs of the MMR proteins, and hence, if a mutation
occurs in MLH1 or MSH2, its binding partner would also
have inhibited expression in epithelial cells. Each pro-
tein subcellular expression pattern mimics the behaviour
observed in real high-resolution IF data. In this way,
we can capture protein co-localisation patterns. In addi-
tion, developing realistic protein expression models could
potentially aid the discovery of yet unknown protein
interactions.
Subcellular Organelle Features
In order to assess the quality of the spatial protein expres-
sion models, we assess how well the cell organelles have
been modelled. We consider how accurately organelle fea-
tures that have been used as input to the model have been
generated within the synthesised data. In order to perform
the comparison, we generated 10 well-differentiated sam-
ples with the same magnification and image resolution
as the real images. This resulted in the generation of
8,663 vesicles, 2,336 golgi and 394 nucleoli. Comparison
of the histograms has been been performed using the
Kullback-Leibler divergence between the real and syn-
thetic distributions. The results are shown in Table 4.
The distributions of the numbers of organelles per cell
and their position are shown in Fig. 16. We can see that
the distributions of the numbers of organelles are rea-
sonably good approximations of the real PDFs. For the
number of golgi, we can see that there are a small num-
ber of cells with a very high number of golgi organelles.
However, a similar, although smaller peak in the his-
togram can be observed in the real data (Fig. 6c). On
the other hand, we can see a wider distributions for the
position parameter of the synthesised golgi and vesicles.
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Fig. 17 Probability distributions for the ratios between the minor axes of the synthesised organelles and the nucleus of the corresponding cell (left
column) and between the minor and major axes of the synthesised organelles (right column). Figures show the ratios for a, b nucleoli, c, d golgi and
e, f vesicles. The probability distribution functions shown are the ones estimated for the real data, shown in Fig. 7
This is due to the fact that when the position of these
organelles is being calculated, the method assumes that
the nucleus is in the centre of the cell, rather than dis-
placed towards the base of the cell. Hence, the problem
does not occur in stromal cells and high-grade cancer
samples. On the other hand, the distributions for the
ratio between the minor axes of the synthesised organelles
and the nucleus of the corresponding cell as shown in
Fig. 17 (left column) and between the minor and major
axes of the synthesised organelles in Fig. 17 (right col-
umn) show very good agreement with the PDFs estimated
from the real data. We have also considered features
that have not been explicitly learned from the real data.
Figure 18 shows the distributions of the solidity for real
and synthesised organelles and we can observe very good
agreement between the two. In Fig. 19 we consider the
area taken up by the organelles. Figure 19a, b shows the
fraction of the nucleus taken by the nucleoli. Figure 19c–d
illustrates the fraction of the total area of the cell taken
by the golgi and vesicles. Although the area of the
organelles is not specified explicitly within the model, we
observe good agreement between the real and synthesised
distributions.
Combinatorial molecular phenotypes
One imaging technique allowing acquisition of multiplex
IF images is the Toponome Imaging System (TIS) [34].
One way of analysing such data is to threshold all the
channels, obtaining at each pixel a 0 where the protein
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Fig. 18 Probability distributions for the real (left column) and synthesised (right column) solidity of the a, b nucleoli, c, d golgi and e, f vesicles. The
probability distribution functions shown are the ones estimated for the real data
is absent and 1 where it is present. Then, the protein
expression signals can be expressed as a binary code called
Combinatorial Molecular Phenotype (CMP) [34, 35]. We
have performed this analysis to compare the CMPs found
in a healthy sample and amoderately differentiated sample
with a mutation in the MLH1 protein. The healthy sample
contained a total of 389 cells, whereas the cancerous sam-
ple contained 455 cells. The results are shown in Fig. 20.
We can see that the stromal cells have been split into
two phenotypes present in both samples. The phenotypes
determined by the expression of PTEN (Fig. 20e), with
cells expressing the protein shown in orange and those
lacking the protein shown in light blue. Each phenotype
is formed of two CMPs, one located in the cell cytoplasm
and one localised to the nucleus and vesicles. The two
CMPs are differentiated by expression of MSH2. The lack
of a purely nuclear marker in the stromal cells means
that the CMP analysis of these cells is unable to segment
the nuclei. On the other hand, P53 has allowed identifi-
cation of nuclei in the healthy epithelial cells expressing
the protein (Fig. 20c) resulting in a unique CMP shown
in dark red in Fig. 20a. In the epithelial cancer cells, the
mutation of MLH1 has resulted in unique CMPs being
identified (Fig. 20f). Similar to the healthy epithelial cells,
the expression of P53 (Fig. 20d) divides the cells into two
phenotypes.
It is clear that this kind of analysis can allow for the
identification of different cell phenotypes and subcellu-
lar compartments that may shed new light on tumour
heterogeneity. In the experiment above, CMP analysis
was unable to identify the nucleoli and golgi apparatus.
This is because the proteins expressed in the nucleoli are
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Fig. 19 Probability distributions for the cell area fraction taken up by the real (left column) and synthesised (right column) organelles. a, b show the
fraction of nuclear area taken up by the nucleoli. The fraction of cytoplasmic area taken up by (c, d) golgi and (e, f) vesicles is also considered. The
probability distribution functions shown are the ones estimated for the real data
also expressed in the nuclei. Similarly, the only protein
expressed in the golgi is also expressed weakly in the cyto-
plasm. If one was interested in identifying these regions,
a higher threshold could be set to ignore weak expression.
However, great care would need to be taken as the tex-
ture of the protein expression may result in holes in the
cytoplasmic or nuclear regions.
Protein network analysis
Kovacheva et al. [36] introduced the DiSWOP framework
for analysing multiplex IF data, such as the one simulated
by the model described above. The approach analyses cell
phenotypes in normal and cancerous colon tissue imaged
using the TIS microscope [34]. It involves segmenting
the image into cells and determining the cell phenotypes
according to their protein-protein dependence profile.
Calculating the DiSWOP measure enables identification
of protein pairs which have significantly higher/lower
co-expression levels in cancerous tissue samples when
compared to normal colon tissue. We apply the DiS-
WOP framework to a set of simulated images. For this
purpose, we generated 10 healthy and 10 moderately dif-
ferentiated cancerous samples at 40×magnification. From
the 10 cancerous samples, 4 had no mutation, 3 had a
mutation in the MLH1 gene and 3 had a mutation in
the MSH2 gene. The same dataset was also simulated at
20× magnification to investigate the dependence of the
DiSWOPmeasure on the magnification scale. This exper-
iment was conducted considering only proteins directly
linked to MSI, i.e. without simulating the expression
of PTEN.
Kovacheva and Rajpoot BMC Bioinformatics  (2016) 17:430 Page 18 of 24
Fig. 20 Combinatorial molecular phenotype analysis. a and b show the CMPs obtained for healthy and cancerous samples, respectively. c and d
show expression of P53 in healthy and cancerous samples, respectively. e shows the expression of PTEN in a healthy sample. f shows expression of
MLH1 in a cancer sample
For each of the cells, we calculate the protein-protein
dependence profile (PPDP) using the Maximal Informa-
tion Coefficient (MIC) [37]. The protein pairs are shown
in Table 5. The cells are phenotyped using Affinity Prop-
agation [38] according to their PPDP. Distribution of
Table 5 Protein pair numbering
PMS2 MSH2 MSH6 P53
MLH1 1 2 3 4
PMS2 5 6 7
MSH2 8 9
MSH6 10
the phenotypes within the cancerous samples simulated
at 40× magnification is shown in Fig. 21. We can see
that phenotypes 7 and 8 are found only in samples with
MLH1 mutation. Their PPDPs are highlighted in red in
Fig. 22. From Fig. 22, we can see that phenotype 7 exhibits
non-zero dependence only between MSH2 and MSH6,
whereas phenotype 8 also has non-zero dependencies
between these two proteins and P53. This can also be
observed from the real data. We can see in Fig. 23 that
the two phenotypes include all of the epithelial cells, with
phenotype 8 including all epithelial cells expressing P53.
On the other hand, phenotypes 10, 11, 12 and 16 are
found only in samples with MSH2 mutation. Phenotypes
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Fig. 21 Distribution of phenotypes within cancer samples simulated
at 40× magnification. Phenotypes are shown along the x-axis and the
fraction of the phenotype that is found within each type of cancer
samples is shown along the y-axis. Cancer samples without mutation
are shown in blue, samples with MLH1 mutation are shown in teal
and yellow shows the samples with MSH2 mutation
Fig. 22 Average protein-protein dependence profiles (PPDPs) for the
phenotypes found within healthy and cancerous samples simulated
at 40× magnification. Phenotypes found only in samples with MLH1
mutation are highlighted in red. Similarly, phenotypes found only in
samples with MSH2 mutation are highlighted in blue. Numbering of
the phenotypes is the same as in Fig. 21. Numbering of the protein
pairs is shown in Table 5. Black indicates PPD value of 0, and white
shows a PPD value of 1
10, and 16 (marked in blue in Fig. 22) show non-zero
dependencies between MLH1, PMS2 and P53, splitting
the epithelial cells expressing P53 in two phenotypes.
These are shown in Fig. 24. This demonstrates that the
clustering is able to detect meaningful cell phenotypes,
although the real phenotypes could be split into two or
more phenotypes found by the algorithm.
Once we have obtained the phenotypes, we calculate the
DiSWOP measure. We consider the top 3 protein pairs
in each phenotype due to their relative significance. The
DiSWOP results for the simulated samples at 40× and
20× magnification are shown in Fig. 25. We can see that
nearly the same results are obtained, demonstrating that
the measure is independent of the magnification scale and
size of the cells. Figure 25 also shows that DiSWOP is able
to detect that the dependences between MLH1, PMS2
and MSH2 are stronger in the healthy samples, suggest-
ing that they are broken in at least some of the cancer
samples. However, it is difficult to interpret the results
further as within the cancer samples there are a number
of non-MSI samples and cells that have the same pro-
tein expressions as the healthy samples. To further analyse
the simulated data, we considered dividing the cancer
samples into three sets depending on the presence of a
mutation. We re-run the analysis framework when con-
sidering non-MSI samples versus MSI samples with both
mutations (Fig. 26a), and versus each mutation separately
(Fig. 26b and c). When samples with both mutations are
considered, the results are very similar to those seen in
Fig. 25. This is due to the fact that the mutations cause
all of the protein pair interactions to be broken down in
some of the samples. However, the negative values again
clearly indicate the lack of co-localisation of the MMR
proteins. On the other hand, if we consider non-MSI sam-
ples versus samples with MLH1 mutation (Fig. 26b), we
can see that, as expected, the interactions of MLH1 and
PMS2 are weaker in the MSI sample while MSH6 shows
stronger interactions with MSH2, P53 and MLH1. The
latter interaction is likely to occur only in the stromal
cells which express all proteins. Lastly, we compared non-
MSI and MSH2 mutated samples (Fig. 26c). As would be
expected, we observe stronger interactions of MSH2 with
other proteins in the non-MSI samples. Themutated sam-
ples are characterised by increased co-localisation of P53
and PMS2.
With this set of proteins, it would be easier to sim-
ply consider the raw protein expression values. This is
because there is no evidence to suggest that the expres-
sion patterns of these proteins within the cells change
as a result of cancer and this has been reflected in the
model. Hence, this experiment aims to demonstrate only
how the DiSWOP framework could be used to analyse
the synthesised data. However, DiSWOP would provide
a significantly greater advantage if the simulated proteins
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Fig. 23 Simulated protein expression in cell phenotypes found only in MLH1 mutated samples. The images show the expression for aMSH2, b
MSH6 and c, d P53. The red outlines indicate the cells belonging to phenotypes (a – c) 7 and (d) 8
Fig. 24 Simulated protein expression in cell phenotypes found only in MSH2 mutated samples. The images show the expression for aMLH1, b
PMS2 and c, d P53. The red outlines indicate the cells belonging to phenotypes (a – c) 10 and (d) 16
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Fig. 25 DiSWOP results for the simulated samples at (a) 40× and (b) 20× magnification. Each node represents a protein and each edge colour
shows a protein pair with different level of co-expression in the normal and cancer samples. Here, a large positive value (shown in red) indicates that
the protein pair is more co-dependent in cancer samples, whereas a large negative value (shown in blue) means that the protein pair is more active
in normal tissue
changed their subcellular expression patterns [36]. Pro-
teins that exhibit such changes in localisation could be
easily modelled using the framework presented above.
These could be proteins with known response to cancer
or one could generate random changes in localisation in
order to test hypotheses.
Conclusions
We presented protein expression models to simulate mul-
tiplexed IF data of both healthy and cancerous colorectal
samples. We investigate how to realisticly simulate the
expression of six proteins associated with MSI or tumour
suppression, namely MLH1, PMS2, MSH2, MSH6, P53
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Fig. 26 DiSWOP results for comparing MSI and non-MSI sets of the simulated cancer samples at 40× magnification. Different results are shown
when comparing non-MSI samples to (a) both mutations, (b) MLH1 mutation only, and (c) MSH2 mutation only. Each node represents a protein and
each edge colour shows a protein pair with different level of co-expression in the normal and cancer samples. Here, a large positive value (shown in
red) indicates that the protein pair is more co-dependent in the mutated samples, whereas a large negative value (shown in blue) means that the
protein pair is more active in non-MSI tissue
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and PTEN. Following the same method, further pro-
teins of interest could be easily added to the model to
increase its usability and study differential co-localisation
of proteins. In order to simulate the subcellular location
of the proteins, we have developed models for the cell
nucleoli, golgi and vesicles, using parameters obtained
from real fluorescence data of cells in culture. Compari-
son between the distribution of various features obtained
from the real and synthetic organelles has shown very
good agreement. This has included both features that
have been used as part of the model input and ones
that have not been explicitly considered. The addition
of further proteins of interest may require more of the
cell organelles to be modelled, such as the cytoskeleton
and the endoplasmic reticulum. It would be difficult to
represent these using the deformed circle model, so a
different approach may need to be developed. We have
analysed simulated data using the combinatorial molec-
ular phenotype analysis and have demonstrated that this
approach is capable of identifying the different cell pheno-
types and subcellular structures in the tissue. Finally, we
presented a study of how the DiSWOP framework could
be used to analyse the synthetic data. Using the frame-
work to compare the protein co-localisation inMSI versus
non-MSI samples was able to detect the presence of muta-
tions. This kind of analysis would be invaluable in detect-
ing changes in subcellular expression patterns resulting
from the development of cancer. Proteins that exhibit
such changes in localisation could be easily modelled
using the framework presented in order to test various
hypotheses.
To the best of our knowledge, this is the first model for
subcellular expression ofmultiple proteins in anatomically
intact tissue, as opposed to existing models for protein
expression within cells in culture. The synthetic data gen-
erated using this model could provide an objective way
of validating and comparing image analysis methods such
as cell-compartment classification methods, frameworks
for studying protein co-localisation or protein expression
grading.
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